Latest Revenue Generation News

Artrya is advancing its commercial footprint in the US with two health systems now generating revenue and FDA clearance for its Salix Coronary Flow module expected in H2 2026.

Prairie Lithium has advanced its Saskatchewan lithium project with the delivery of North America’s largest commercial Direct Lithium Extraction unit and a binding offtake agreement securing 100% of Phase 1 production.

Dotz Nano has appointed Nati Harpaz as CEO, introduced Dotz Energy to extend its decarbonisation efforts, and secured $3.3 million in fresh funding to accelerate commercialisation and production scale-up.

Yojee has transitioned its MOSAIC freight forwarding platform into commercial operations, securing multiple contracts including two long-term Everest Founding Partners and outlining a strategic AI-driven roadmap.

Xenitra has secured a three-year procurement agreement worth at least A$12 million with Kangsheng, a leading Chinese pharmaceutical distributor, marking its OTC pharmaceuticals division's shift from setup to commercial execution.

Artrya has launched its AI-powered Salix platform at Northeast Georgia Health System, marking its second U.S. commercial customer with active revenue streams from subscription and fee-per-scan models.

Vitrafy Life Sciences has partnered with the historic Hoxworth Blood Center to deploy its next-generation cryopreservation technology, aiming to address a critical gap in red blood cell preservation ahead of legacy technology discontinuation in 2027.

Activeport signs GOIP Globalnet to its Global Edge network, marking the third international carrier deal in a week and reinforcing its strategy for recurring revenue growth.

St Barbara Limited reported an 8% increase in gold production for Q4 FY26, with attributable output from New Simberi Gold beating previous guidance. The company maintains a robust balance sheet with A$509 million in cash, bullion, and listed investments, while remaining debt-free.

Wingara AG appoints Christopher Hood as CEO, aiming to boost its hay trading and agricultural logistics business with a significant equity-linked remuneration package.

Cyclopharm has landed a major US expansion deal with University Hospitals Cleveland, deploying Technegas® across 11 sites simultaneously and boosting its recurring revenue base in the Midwest.

Within six weeks of commissioning, Aguia Resources has secured over A$2.3 million in sales of its Pampafos organic phosphate fertiliser, marking a key transition to revenue-generating operations with deliveries scheduled through year-end.